Concepedia

Elizabeth M. Coyle

EM

Statistics

Publications

25

Citations

1.5K

H-Index

20

Active since

2013

Affiliations

Center for Biologics Evaluation and Research(Current)

National Institute of Allergy and Infectious Diseases

United States Food and Drug Administration

National Institutes of Health

University of Rochester Medical Center

Elizabeth M. Coyle is an author at Center for Biologics Evaluation and Research specializing in infectious diseases, immunology, and viral vaccines.

Publications per year

2013–2024

25

Publications

25

Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits

Supriya Ravichandran, Elizabeth M. Coyle, Laura Klenow et al. · Science Translational Medicine · 2020 · 217 citations · Full text

, , +15

Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial

Richard T. Davey, Eduardo Fernández‐Cruz, Norman Markowitz et al. · The Lancet Respiratory Medicine · 2019 · 134 citations · Full text

, , +12

Repeat vaccination reduces antibody affinity maturation across different influenza vaccine platforms in humans

Surender Khurana, Megan Hahn, Elizabeth M. Coyle et al. · Nature Communications · 2019 · 99 citations · Full text

, , +17

Antibody affinity maturation and plasma IgA associate with clinical outcome in hospitalized COVID-19 patients

Juanjie Tang, Supriya Ravichandran, Youri Lee et al. · Nature Communications · 2021 · 88 citations · Full text

, , +16

Human antibody repertoire after VSV-Ebola vaccination identifies novel targets and virus-neutralizing IgM antibodies

Surender Khurana, Sandra Fuentes, Elizabeth M. Coyle et al. · Nature Medicine · 2016 · 87 citations · Full text

, , +16

1–5 of 25